Rita joined NLC in April 2022 as a Venture Developer in the biotech team. She holds a BSc in Biology and an MSc in Molecular Genetics and Biomedicine and is currently finishing her PhD in Bioengineering under the MIT-Portugal Program. Rita has +6 years of R&D experience, mainly in in-vitro/ex-vivo preclinical models, nanotechnology and omics/AI-based strategies in precision medicine applied to oncology. Rita has an entrepreneurial mindset and participated in 7 business/innovation-related courses, including a mini-MBA for life scientists. She aims to help bring new healthtech from the lab to the market to solve unmet medical needs and improve patients’ lives.